Officer Paula Green Files Intent to Sell $2.13M in Twist Bioscience Stock
TWST has more than doubled off its 52-week low of $23.3.
Summary
An officer at Twist Bioscience has filed an intent to sell over $2.1 million in company stock, acquired via option exercise, adding to recent insider selling activity and occurring near the stock's 52-week high.
Key Events · Ownership and Investor Activity · TWST
-
Officer Files Intent to Sell
Paula Green, an Officer, has filed a Form 144 to sell 26,137 shares of common stock, valued at approximately $2.13 million.
-
Shares Acquired via Option Exercise
The shares intended for sale were acquired through a stock option exercise on the same day as the proposed sale.
-
Adds to Insider Distribution Trend
This filing contributes to a broader trend of insider selling, with over $8.8 million in net sales by insiders in the last 90 days.
-
Sale Near 52-Week High
The proposed sale comes as Twist Bioscience stock is trading near its 52-week high of $82.99, potentially indicating profit-taking.
Analysis · TWST · Life Sciences
Paula Green, an Officer, has filed a Form 144 indicating an intent to sell approximately $2.13 million worth of Twist Bioscience common stock. These shares were acquired through a stock option exercise on the same day. This transaction adds to a pattern of insider selling observed over the past 90 days, contributing to a net distribution signal. The proposed sale occurs while the stock is trading near its 52-week high, suggesting the officer is taking profits from exercised options.
How filings like this one have moved
In the 30 days to Sep 16, 2026, 29.6% of the 1725 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.33%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, TWST was trading at $81.70 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $5.1B. The 52-week trading range was $23.30 to $82.99. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.